<?xml version="1.0" encoding="UTF-8"?>
<p id="Par99">In patients with Parkinsonâ€™s disease COVID-19 worsens motor and non-motor symptoms, with urinary abnormalities and fatigue being prominent [
 <xref ref-type="bibr" rid="CR110">110</xref>]. In this study symptoms and signs one might ascribe to autonomic failure were unaffected. Serum neurofilament light chain levels, a biomarker of axonal damage, have been reported to be increased in COVID-19 patients [
 <xref ref-type="bibr" rid="CR116">116</xref>]. Although patients with increased serum neurofilament light chain levels have been reported to be more likely to require intubation, the levels seem unrelated to neurologic symptoms.
</p>
